Inventor
TRAVERSE JOHN FITZGERALD
US8 patents
⚠️ This page may combine multiple inventors who share the name “TRAVERSE JOHN FITZGERALD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CELGENE CORP
4 patentsUS11014940B1May 25, 2021
Thiazolidinone and oxazolidinone compounds and formulations
CELGENE CORP0 citations59
US12227519B2Feb 18, 2025
Preparation of maytansinol
CELGENE CORP0 citations54
US9969712B2May 15, 2018
Process for the preparation of isotopologues of 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and pharmaceutically acceptable salts thereof
CELGENE CORP0 citations47
US9695145B2Jul 4, 2017
Processes for the preparation of isotopologues of 3-(4-((4- morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and pharmaceutically acceptable salts thereof
CELGENE CORP0 citations47
SIGNAL PHARM LLC
3 patentsUS9604939B2Mar 28, 2017
Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-YL)pyridin-3-YL)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-B]pyrazin-2(1H)-one, a solid form thereof and methods of their use
SIGNAL PHARM LLC1 citations59
US9974786B2May 22, 2018
Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino[2,3- B]pyrazin-2(1H)-one, a solid form there of and methods of their use
SIGNAL PHARM LLC0 citations48
US9795603B2Oct 24, 2017
Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-B]pyrazin-2(1H)-one, a solid form thereof and methods of their use
SIGNAL PHARM LLC0 citations48